메뉴 건너뛰기




Volumn 376, Issue 9743, 2010, Pages 768-769

Authors' reply

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; CORTICOSTEROID; NIFURTIMOX; PLACEBO;

EID: 77956383780     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61373-6     Document Type: Letter
Times cited : (2)

References (5)
  • 1
    • 64049108552 scopus 로고    scopus 로고
    • Side effects of benznidazole as treatment in chronic Chagas disease: Fears and realities
    • R Viotti, C Vigliano, B Lococo Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities Expert Rev Anti Infect Ther 7 2009 157 163
    • (2009) Expert Rev Anti Infect Ther , vol.7 , pp. 157-163
    • Viotti, R.1    Vigliano, C.2    Lococo, B.3
  • 2
    • 33646847271 scopus 로고    scopus 로고
    • Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: A nonrandomized trial
    • R Viotti, C Vigliano, B Lococo Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial Ann Intern Med 144 2006 724 734
    • (2006) Ann Intern Med , vol.144 , pp. 724-734
    • Viotti, R.1    Vigliano, C.2    Lococo, B.3
  • 4
    • 36148997207 scopus 로고    scopus 로고
    • Evaluation and treatment of Chagas disease in the United States: A systematic review
    • C Bern, SP Montgomery, BL Herwaldt Evaluation and treatment of Chagas disease in the United States: a systematic review JAMA 298 2007 2171 2181
    • (2007) JAMA , vol.298 , pp. 2171-2181
    • Bern, C.1    Montgomery, S.P.2    Herwaldt, B.L.3
  • 5
    • 45549100534 scopus 로고    scopus 로고
    • Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT)
    • BENEFIT Investigators C.A.
    • JA Marin-Neto, A Rassi Jr, CA Morillo BENEFIT Investigators Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT) Am Heart J 156 2008 37 43
    • (2008) Am Heart J , vol.156 , pp. 37-43
    • Marin-Neto, J.A.1    Morillo2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.